ALNYLAM UK LIMITED

1. Company facts

Status

active

Lifecycle

🌳 Mature — Long-running with flat or slow growth. Steady cash, limited upside.

Jurisdiction

england-wales

Registered office

Point, 27 Market Street, Maidenhead, SL6 8AA, United Kingdom

SIC codes

72110 — Research and experimental development on biotechnology

Accounts next due

2026-09-30

Confirmation statement next due

2027-02-14

2. Directors (3 active)

PAGNANO, Carlos Arnaldo Dal Secco

director · appointed 2023-06-06 · born 6/1979 (age 47)

POULTON, Jeffrey Vernon

director · appointed 2019-08-13 · born 11/1967 (age 59)

WITKOS, Katarzyna Maria

director · appointed 2021-09-13 · born 5/1972 (age 54)

3. Shareholders (1 active)

Alnylam Pharmaceuticals Inc

75-100% shares · 75-100% voting · board control

4. Group structure

Alnylam Pharmaceuticals Inc is the ultimate parent — holding 75%+ shares. This company sits inside their group.

Alnylam Pharmaceuticals Inc

Corporate parent · 75-100%

Headline verdict

Opportunity score

77/100 (Strong)

Owner dependency

moderate — 58/100

Red flags

0 high · 0 medium · 1 low